Related Experiment Video
Updated: May 6, 2026

Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds
Published on: September 8, 2021
Oxadiazolone Derivatives: Powerful Tools to Reduce Staphylococcus aureus Infection.
Emma Forest1,2, Jordan Lehoux3, Léo Faion3
1Aix Marseille Univ., CNRS, LISM UMR7255, Marseille 13402 cedex 20, France.
New oxadiazolone derivatives show potent antibacterial activity against Staphylococcus aureus. These compounds target planktonic, intracellular, and biofilm forms, offering a promising new class of antimicrobials to combat resistance.
Area of Science:
- Microbiology and Infectious Diseases
- Medicinal Chemistry
- Biochemistry
Background:
- Staphylococcus aureus is a high-priority pathogen due to antimicrobial resistance, virulence, and ability to form biofilms and persist intracellularly.
- Difficult-to-treat S. aureus infections necessitate the development of novel chemical classes with unique mechanisms of action.
- Oxadiazolone-core derivatives (OXs) represent a potential new chemotype for antibacterial drug discovery.
Purpose of the Study:
- To investigate the antibacterial activity of oxadiazolone derivatives against planktonic, intracellular, and biofilm-associated Staphylococcus aureus.
- To identify the molecular targets of active oxadiazolone derivatives using activity-based protein profiling and mass spectrometry.
Main Methods:
- Screening of oxadiazolone derivatives for antibacterial activity against S. aureus in planktonic, intracellular, and biofilm models.
- Determination of minimum inhibitory concentrations (MICs) for active compounds.
- Activity-based protein profiling (ABPP) coupled with mass spectrometry to identify enzyme targets.
Main Results:
- MpPPOX demonstrated bactericidal activity against extracellular S. aureus with an MIC comparable to vancomycin.
- iBPOX primarily inhibited intracellular S. aureus replication, while HPOX significantly impaired initial biofilm formation.
- ABPP identified that HPOX targets enzymes involved in biofilm formation and virulence; iBPOX and MpPPOX target multiple (Ser/Cys)-based enzymes, including FabH for MpPPOX.
Conclusions:
- Oxadiazolone derivatives exhibit diverse activities against S. aureus, including extracellular, intracellular, and antibiofilm effects.
- These compounds act via covalent binding to multiple (Ser/Cys)-based enzymes, highlighting their multitarget nature.
- Oxadiazolones are versatile chemotypes with potential as broad-spectrum antimicrobial agents, capable of enhancing existing therapies.
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Clinical Significance of Antibiotic Resistance
Inhibitors of Bacterial Protein Synthesis
Antimicrobial Effectiveness
Hand hygiene
Hand washing...
Staphylococcal Skin Infections

